FDA Publishes New Guidance on Compounding Animal Drugs from Bulk Drug Substances
On April 14, 2022, the Food and Drug Administration (FDA) published its guidance for industry #256 (GFI 256), describing FDA’s position on the legality of compounding animal drugs from bulk ingredients and the limited circumstances under which FDA will exercise enforcement discretion.

GADA Joins the Food and Drug Law Institute (FDLI)
GADA is now a member of the Food and Drug Law Institute, a nonprofit membership organization that offers education, training, publications, and professional engagement opportunities in the field of food and drug law. As a neutral convener, FDLI provides a venue for stakeholders to inform innovative public policy, law, and regulation. More information on FDLI, click here.

GADA Enters into Reciprocal Membership with IPEC Americas
GADA has entered into a reciprocal membership with IPEC Americas. IPEC-Americas is a U.S. trade association whose members include excipient producers, distributors, and finished drug manufacturers, as well as companies and individuals that supply other specialized services to industry segments.

GADA-CVM Triannual Meeting Summary & Debrief Meeting Recording Available
GADA Members: log in and head to the GADA Knowledge Mine to access the written Summary of the February 24, 2022 Triannual meeting including a link to the recorded Member Debrief session that followed.

2022 GADA-CVM Meeting Schedule

Wednesday, June 22, 2022

GADA Mid-Year Member Meeting
9:00am – 5:00 pm EDT

Thursday, June 23, 2022

GADA-DGAD Meeting
9:00am – 11:30am EDT

GADA-DMT Meeting
1:30pm – 3:00pm EDT

Wednesday, October 26, 2022
GADA Annual Member Meeting
9:00am - 5:00pm EDT

Thursday, October 27, 2022

GADA-DGAD Meeting
9:00am - 11:30am EDT

GADA-DMT Meeting
1:00pm - 3:00pm EDT